ID
20626
Description
A Study of MabThera (Rituximab) Plus Chlorambucil in Patients With Chronic Lymphocytic Leukemia.; ODM derived from: https://clinicaltrials.gov/show/NCT00532129
Link
https://clinicaltrials.gov/show/NCT00532129
Keywords
Versions (1)
- 3/7/17 3/7/17 -
Uploaded on
March 7, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Lymphocytic Leukemia, Chronic NCT00532129
Eligibility Lymphocytic Leukemia, Chronic NCT00532129
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
previous treatment for cll
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1514463
- UMLS CUI [1,2]
- C0023434
Description
concomitant hematological malignancy
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0243087
- UMLS CUI [1,2]
- C0376545
Description
transformation to aggressive b-cell malignancy
Data type
boolean
Alias
- UMLS CUI [1,1]
- C3149729
- UMLS CUI [1,2]
- C0023434
Description
history of severe cardiac disease
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0262926
- UMLS CUI [1,2]
- C0018799
- UMLS CUI [1,3]
- C0205082
Description
hypersensitivity murine antibodies
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0020517
- UMLS CUI [1,2]
- C2916903
Similar models
Eligibility Lymphocytic Leukemia, Chronic NCT00532129
- StudyEvent: Eligibility
C3888518 (UMLS CUI [1,2])
C0332155 (UMLS CUI [2])
C0332121 (UMLS CUI [2,1])
C0023434 (UMLS CUI [2,2])
C0023434 (UMLS CUI [1,2])
C0376545 (UMLS CUI [1,2])
C0023434 (UMLS CUI [1,2])
C0018799 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,3])
C2916903 (UMLS CUI [1,2])